Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

335 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party.
Koenecke C, Heim D, van Biezen A, Heuser M, Aljurf M, Kyrcz-Krzemien S, Volin L, de Souza CA, Gedde-Dahl T, Sengeloev H, Schanz U, Komarnicki M, Arroyo CH, Tholouli E, Gluckman E, Esquirol A, Yakoub-Agha I, Gürman G, Olavarria E, Kröger N. Koenecke C, et al. Among authors: de souza ca. Bone Marrow Transplant. 2016 Sep;51(9):1259-61. doi: 10.1038/bmt.2016.97. Epub 2016 Apr 25. Bone Marrow Transplant. 2016. PMID: 27111041 Free article. No abstract available.
Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT.
Chalandon Y, Passweg JR, Schmid C, Olavarria E, Dazzi F, Simula MP, Ljungman P, Schattenberg A, de Witte T, Lenhoff S, Jacobs P, Volin L, Iacobelli S, Finke J, Niederwieser D, Guglielmi C; Chronic Leukemia Working Party of European Group for Blood and Marrow Transplantation. Chalandon Y, et al. Bone Marrow Transplant. 2010 Mar;45(3):558-64. doi: 10.1038/bmt.2009.177. Epub 2009 Jul 27. Bone Marrow Transplant. 2010. PMID: 19633691
A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies.
Vigorito AC, Azevedo WM, Marques JF, Azevedo AM, Eid KA, Aranha FJ, Lorand-Metze I, Oliveira GB, Correa ME, Reis AR, Miranda EC, de Souza CA. Vigorito AC, et al. Among authors: de souza ca. Bone Marrow Transplant. 1998 Dec;22(12):1145-51. doi: 10.1038/sj.bmt.1701510. Bone Marrow Transplant. 1998. PMID: 9894716 Clinical Trial.
Major salivary gland damage in allogeneic hematopoietic progenitor cell transplantation assessed by scintigraphic methods.
Coracin FL, Pizzigatti Correa ME, Camargo EE, Peterson DE, de Oliveira Santos A, Vigorito AC, Borba Oliveira G, de Brito Eid KA, Zulli R, De Souza CA. Coracin FL, et al. Among authors: de oliveira santos a, de brito eid ka, de souza ca. Bone Marrow Transplant. 2006 May;37(10):955-9. doi: 10.1038/sj.bmt.1705351. Bone Marrow Transplant. 2006. PMID: 16565740
Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome.
De Souza CA, Vigorito AC, Ruiz MA, Nucci M, Dulley FL, Funcke V, Tabak D, Azevedo AM, Byington R, Macedo MC, Saboya R, Penteado Aranha FJ, Oliveira GB, Zulli R, Martins Miranda EC, Azevedo WM, Lodi FM, Voltarelli JC, Simões BP, Colturato V, De Souza MP, Silla L, Bittencourt H, Piron-Ruiz L, Maiolino A, Gratwohl A, Pasquini R. De Souza CA, et al. Among authors: de souza mp. Haematologica. 2005 Feb;90(2):232-7. Haematologica. 2005. PMID: 15710577
Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection.
Dulley FL, Vigorito AC, Aranha FJ, Sturaro D, Ruiz MA, Saboya R, Macedo MC, Da Silva RL, Chamone DA, Mehta J, Bacigalupo A, De Souza CA. Dulley FL, et al. Among authors: de souza ca. Bone Marrow Transplant. 2004 Jan;33(1):9-13. doi: 10.1038/sj.bmt.1704325. Bone Marrow Transplant. 2004. PMID: 14578930 Clinical Trial.
Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trial.
Apperley JF, Cortes JE, Kim DW, Roy L, Roboz GJ, Rosti G, Bullorsky EO, Abruzzese E, Hochhaus A, Heim D, de Souza CA, Larson RA, Lipton JH, Khoury HJ, Kim HJ, Sillaber C, Hughes TP, Erben P, Van Tornout J, Stone RM. Apperley JF, et al. Among authors: de souza ca. J Clin Oncol. 2009 Jul 20;27(21):3472-9. doi: 10.1200/JCO.2007.14.3339. Epub 2009 Jun 1. J Clin Oncol. 2009. PMID: 19487385 Free PMC article. Clinical Trial.
Pretransplant β2-Microglobulin Is Associated with the Risk of Acute Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplant.
Costa-Lima C, Miranda ECM, Colella MP, Aranha FJP, de Souza CA, Vigorito AC, De Paula EV. Costa-Lima C, et al. Among authors: de paula ev, de souza ca. Biol Blood Marrow Transplant. 2016 Jul;22(7):1329-1332. doi: 10.1016/j.bbmt.2016.03.024. Epub 2016 Apr 1. Biol Blood Marrow Transplant. 2016. PMID: 27044906 Free article.
335 results